drugset / Trial / NCT00930215
Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males
RandomizedSingle-groupOpen-label
Summary
The purpose of the study is to determine whether the HPMC capsule of D961H 40 mg is bioequivalent to gelatine capsules of D961H 40 mg after a steady state is reached on Day 5
Timeline
- Start
- 2009-06
- Primary completion
- —
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D961H | Unknown | 40 mg | Oral |
Indications
No indication recorded.